Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
February 24, 2020

Lundbeck gets FDA nod for migraine prevention drug Vyepti

Lundbeck, a Danish pharmaceutical company, has secured approval from the US Food and Drug Administration (FDA) for its Vyepti as a preventive treatment for migraine in adult patients.

Continue
Lundbeck headquarters in Valby, Denmark. Photo: courtesy of H. Lundbeck A/S.
February 24, 2020

Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients

Lilly secures expanded FDA approval for Trulicity. (Credit: Momoneymoproblemz/Wikipedia.org)
February 21, 2020

GSK signs cancer therapies deal with Immatics Biotechnologies

GSK and Immatics will develop next-generation TCR therapeutics to treat solid tumors (Credit: GlaxoSmithKline plc)

Contracts

November 22, 2019

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

Image: ViiV Healthcare to develop investigational bNAbs. Photo: Courtesy of GlaxoSmithKline plc.

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

Deals

Deals February 20, 2020

Humanetics acquires manufacturing assets for radioprotectant drug

Pharmaceutical Business Review

Dr. Reddy’s Laboratories to acquire select business divisions of Wockhardt in India

Ligand agrees to acquire core assets, partnered programmes and ion channel technologies from Icagen

Valeritas announces agreement for Zealand Pharma to acquire business and retain employees

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

Porton Biopharma – Erwinase® Manufacturing Schedule
Porton Biopharma – Erwinase® Manufacturing Schedule
Pharmaceutical Business Review
Denny Bros’ Green Credentials Underlined by 2019 Statistics
Pharmaceutical Business Review
Actide to Attend 5th European Conference for Clinical Research
SGS 2019 Full Year Results
SGS 2019 Full Year Results
Upcoming Pharma Courses
Upcoming Pharma Courses

Suppliers

Whitepapers

Registration of pharmaceutical products and substances
Registration of pharmaceutical products and substances
Trademark and intellectual property registration services
Trademark and intellectual property registration services
Improving Security in the Pharmaceutical Industry
Improving Security in the Pharmaceutical Industry